Mind Medicine (MindMed) Inc.
MMED
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -16.04% | -7.48% | 6.70% | 6.58% | 45.81% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.60% | 10.71% | 9.46% | 11.81% | 38.61% |
| Operating Income | -19.60% | -10.71% | -9.46% | -11.81% | -38.61% |
| Income Before Tax | 38.06% | -13.52% | -27.39% | -35.45% | -98.41% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 38.06% | -13.52% | -27.39% | -35.45% | -98.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 38.06% | -13.52% | -27.39% | -35.45% | -98.41% |
| EBIT | -19.60% | -10.71% | -9.46% | -11.81% | -38.61% |
| EBITDA | -425.28% | -- | -410.41% | -49.43% | 54.66% |
| EPS Basic | 67.80% | 26.26% | 0.06% | -7.76% | -50.97% |
| Normalized Basic EPS | 66.60% | 24.81% | -1.72% | -9.44% | -50.97% |
| EPS Diluted | 56.07% | 15.14% | -13.73% | -16.09% | -51.52% |
| Normalized Diluted EPS | 67.16% | 25.23% | -1.20% | -9.19% | -50.97% |
| Average Basic Shares Outstanding | 91.61% | 79.82% | 54.39% | 39.01% | 24.78% |
| Average Diluted Shares Outstanding | 96.26% | 83.47% | 58.10% | 41.37% | 24.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |